Cardiawave

company

About

Cardiawave is a medical device company .

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$8.20M
Industries
Collaboration,Health Care,Medical Device
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in ultrasound imaging and therapy, and the team at the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging.

Led by an experienced management team, 2017 Prizewinner of Worldwide Innovation Contest 3rd phase, Cardiawave has secured over €14m since inception, to develop its product and to pursue preclinical studies before first-in-man expected in 2019.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$8.20M €1.40M
Cardiawave has raised a total of $8.20M €1.40M in funding over 2 rounds. Their latest funding was raised on Sep 27, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 27, 2018 Series Unknown $8.20M 2 Detail
Mar 2, 2017 Series Unknown €1.40M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Cardiawave is funded by 2 investors. European program Instrument PME and Business Angels des Grandes Ecoles are the most recent investors.
Investor Name Lead Investor Funding Round
European program Instrument PME Series Unknown
Business Angels des Grandes Ecoles Series Unknown